National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 8) (PB 98 of 2015) (Cth)

PB 98 of 2015

National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 8)

National Health Act 1953

I, KAREN BINNEKAMP, Assistant Secretary (Acting), Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated        29          September 2015

KAREN BINNEKAMP

Assistant Secretary (Acting)
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health

Part 1         Preliminary

1. Name of Determination

   (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 8).

   (2)   This Determination may also be cited as PB 98 of 2015.

2. Commencement

   This Determination commences on 1 October 2015.

3. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

   Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Tocilizumab

Insert

Tofacitinib